Salvage treatment in patients with recurrent or resistant malignant pleura mesothelioma. A retrospective study from tertiary oncology department

被引:0
|
作者
Charpidou, Andriani
Tsironis, George
Tsagouli, Sofia
Nikolaou, Aris
Bassias, Antonis
Kainis, Ilias
Zontanos, Marios
Tsimpoukis, Sotiris
Syrigos, Kosts
机构
关键词
Mesothelioma; Lung cancer / Oncology;
D O I
10.1183/13993003.congress-2016.PA5074
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA5074
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Clinical spectrum and outcomes of carbapenem resistant infections in patients with acute leukaemia: A clinical study from a tertiary oncology centre in India
    Hari, Vishnu
    Prakash, N. P.
    Nath, Swapna R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Accuracy of pleural fluid cytology in patients with malignant pleural effusion from non-small-cell lung cancer, pulmonary metastases and pleural mesothelioma. A case-control study
    Lumachi, F.
    Del Conte, A.
    Sulfaro, S.
    Chiara, G. B.
    Basso, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S75 - S75
  • [23] Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study
    Kentepozidis, N.
    Soultati, A.
    Giassas, S.
    Vardakis, N.
    Kalykaki, A.
    Kotsakis, A.
    Papadimitraki, E.
    Pantazopoulos, N.
    Bozionellou, V.
    Georgoulias, V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 161 - 168
  • [24] Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study
    N. Kentepozidis
    A. Soultati
    S. Giassas
    N. Vardakis
    A. Kalykaki
    A. Kotsakis
    E. Papadimitraki
    N. Pantazopoulos
    V. Bozionellou
    V. Georgoulias
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 161 - 168
  • [25] Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study
    Yu, Shufei
    Wang, Yan
    Li, Junling
    Hao, Xuezhi
    Wang, Bin
    Wang, Ziping
    Zhang, Xiangru
    Shi, Yuankai
    THORACIC CANCER, 2013, 4 (02) : 109 - 116
  • [26] Outcomes of patients with systolic heart failure presenting with sepsis to the emergency department of a tertiary hospital: a retrospective chart review study from Lebanon
    Abou Dagher, Gilbert
    Hajjar, Karim
    Khoury, Christopher
    El Hajj, Nadine
    Kanso, Mohammad
    Makki, Maha
    Mailhac, Aurelie
    Chebl, Ralphe Bou
    BMJ OPEN, 2018, 8 (07):
  • [27] Clinical Characteristics of Local Recurrent Basal Cell Carcinoma After Surgical Excision: A Retrospective Study of the Patients From a Tertiary Clinical Center
    Avci, Elif Bal
    Aksu, Ayse Esra Koku
    Erdil, Dilara Ilhan
    Erdemir, Vefa Asli
    Leblebici, Cem
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [28] Clinical and histopathological characteristics of primary and recurrent basal cell carcinoma: a retrospective study of the patients from a tertiary clinical centre in the northern Poland
    Plaszczynska, Anna
    Skibinski, Robert
    Slawinska, Martyna
    Biernat, Wojciech
    Lesiak, Aleksandra
    Nowicki, Roman
    Sobjanek, Michal
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2022, 39 (01): : 126 - 131
  • [29] A retrospective validation study of three models to estimate the probability of malignancy in patients with small pulmonary nodules from a tertiary oncology follow-up centre
    Talwar, A.
    Rahman, N. M.
    Kadir, T.
    Pickup, L. C.
    Gleeson, F.
    CLINICAL RADIOLOGY, 2017, 72 (02) : 177.e1 - 177.e8
  • [30] Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital
    Avcu, Gulhadiye
    Erci, Ece
    Bilen, Nimet Melis
    Ersayoglu, Irem
    Ozek, Gulcihan
    Celtik, Ulgen
    Terek, Demet
    Cilli, Feriha
    Bal, Zumrut Sahbudak
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024,